Warning letter · FDA Warning Letters

Fertility Nutraceuticals LLC: FDA Warning Letter 605595 (May 20, 2021)

Agency action: May 20, 2021Record ID: fda_warning_-d3c412fcb13ef84e
View official source ↗

What happened

Original notice title

Fertility Nutraceuticals LLC MARCS-CMS 605595, May 20, 2021

From the archived source record

A 2007 study demonstrated that DHEA decreases the miscarriage rate of women” Article titled: “ 4 Important Fertility Questions Answered ”: • “Fertinatal Fertility DHEA has been show in multiple studies to . . . reduce miscarriage risk.” On the website www.fertilitysupplementstore.com: On the “Supplement Guide” page: • “FERTINATAL® DHEA For Women is recommended for:… Women . . . receiving fertility treatment...” • “CONFLAM-Forte™ . . . is recommended for: Women with evidence of inflammation. . . Women . . . with high miscarriage risk” On the “CONFLAM-Forte™” page: • “…Fertility Doctors Recommend Conflam-Forte . . . A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your “CONFLAM Forte™” product fails to bear adequate directions for its intended use and, therefore, this product is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of this misbranded drug violates section 301(a) of the Act [21 U.S.C. § 331(a)]. This letter is not intended to be an all-inclusive statement of violations that may exist in connection with your products. You are responsible for investigating and determining the causes of any violations and for preventing their recurrence or the occurrence of other violations. This letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may result in legal action including, without limitation, seizure and injunction. Please notify FDA in writing, within 15 working days of receipt of this letter, of the specific steps you have taken to address any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
No closeout listed in FDA table
Source checked
Jul 16, 2026
Record revision
a777238f856e

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
CONFLAM- Forte™; FERTINATAL® DHEA; OVOENERGEN™ CoenzymeQ10; Supplement Guide; [C]omprehensive Inflammation-Modulating Nutritional Supplement for Fertility
Company
Fertility Nutraceuticals LLC
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.